Beijing Records Double Number Of Breast Cancers Over Past Decade
This article was originally published in PharmAsia News
Executive Summary
China's capital of Beijing experienced a doubling of breast-cancer cases over the past 10 years, partially because younger women are developing the disease. A city pilot program was begun last year in certain parts of the city to offer free screening for breast and cervical cancers. The program was expanded beginning in April to cover all Beijing districts this year. Breast cancer now accounts for a third of disease-related deaths in the city, up from a ranking of fifth a decade ago. (Click here for more
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.